A Safety and PK Study of IV Eravacycline
NCT03696550
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Infections
Interventions
DRUG:
Eravacycline (TP-434)
Sponsor
Tetraphase Pharmaceuticals, Inc